8-K filing — ACCENDRA HEALTH INC/VA/ (ACH)
Filed: 2026-08-17 AccNo: 0001104659-26-097517 Size: 203 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Accendra Health Adopts Section 382 Rights Agreement To Protect Long-Term Shareholder Value By Preserving Its Net Operating Loss Carryforwards
A company generally experiences an ownership change if the percentage of the value of its stock owned by certain "5-percent shareholders," as such term is defined in Section 382 of the Code, increases by more
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Accendra Health Updates Capital Plans; Nets $45M From Non-Core Asset Sales And Sets CEO Succession Timeline For September
Accendra Health (the "Company") is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer.Given recent market conditions, the Company has
UBS Maintains Neutral on Accendra Health, Lowers Price Target to $1.5
UBS analyst Kevin Caliendo maintains Accendra Health (NYSE:ACH) with a Neutral and lowers the price target from $4.5 to $1.5.
Accendra Health shares are trading lower after Citigroup downgraded the stock from Buy to Neutral rating and lowered the price target from $4.5 to $1.5.